Comparison of the effect of acarbose, metformin and glipizide on newly diagnosed young type 2 diabetic patients
- VernacularTitle:阿卡波糖、二甲双胍、格列吡嗪在新诊断青年2型糖尿病患者中应用的比较
- Author:
Lulu CHEN
;
Juan ZHENG
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus, type 2;
Acarbose;
Metformin;
Glipizide
- From:Chinese Journal of Endocrinology and Metabolism
2001;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Ninty-four newly diagnosed young type 2 diabetic patients were treated by acarbose, metformin or glipizide for 36 weeks. The results showed that these drugs had similar effects in reducing blood glucose. Acabose decreased postprandial insulin secretion and had higher safety and better compliance. It was appropriate to use in newly diagnosed young type 2 diabetic patients.
